Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis

The treatment of locally recurrent lung cancer is a major challenge for radiation-oncologists, especially with data on high-dose reirradiation being limited to small retrospective studies. The aim of the present study is to assess overall survival (OS) for patients with locally recurrent lung cancer after high-dose thoracic reirradiation. Thirty-nine patients who were re-irradiated for lung cancer relapse between October 2013 and February 2019 were eligible for the current retrospective analysis. All patients were re-irradiated with curative intent for in-field tumor recurrence. The diagnostic work-up included a mandatory 18F-FDG-PET-CT scan and—if possible—histological verification. The ECOG was ≤2, and the interval between initial and second radiation was at least nine months. Thirty patients (77%) had non-small cell lung cancer (NSCLC), eight (20%) had small cell lung cancer (SCLC), and in one patient (3%) histological confirmation could not be obtained. More than half of the patients (20/39, 51%) received re-treatment with dose differentiated accelerated re-irradiation (DART) at a median interval of 20.5 months (range: 6–145.3 months) after the initial radiation course. A cumulative EQD2 of 131 Gy (range: 77–211 Gy) in a median PTV of 46 mL (range: 4–541 mL) was delivered. Patients with SCLC had a 3 mL larger median re-irradiation volume (48 mL, range: 9–541) compared to NSCLC patients (45 mL, range: 4–239). The median cumulative EQD2 delivered in SCLC patients was 84 Gy (range: 77–193 Gy), while NSCLC patients received a median cumulative EQD2 of 135 Gy (range: 98–211 Gy). The median OS was 18.4 months (range: 0.6–64 months), with tumor volume being the only predictor (p < 0.000; HR 1.007; 95%-CI: 1.003–1.012). In terms of toxicity, 17.9% acute and 2.6% late side effects were observed, with a toxicity grade >3 occurring in only one patient. Thoracic high dose reirradiation plays a significant role in prolonging survival, especially in patients with small tumor volume at recurrence.

[1]  C. Nieder,et al.  Provider decision regret—a useful method for analysis of palliative thoracic re-irradiation for lung cancer? , 2020, Strahlentherapie und Onkologie.

[2]  F. Sedlmayer,et al.  Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer , 2019, Thoracic cancer.

[3]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2019 with focus on breast cancer. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  J. Debus,et al.  Re-irradiation in locally recurrent lung cancer patients , 2019, Strahlentherapie und Onkologie.

[5]  M. Duma,et al.  Prognostic factors in stereotactic body radiotherapy of lung metastases , 2018, Strahlentherapie und Onkologie.

[6]  G. Hanna,et al.  Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[7]  F. Sedlmayer,et al.  DART-bid for loco-regionally advanced NSCLC , 2017, Strahlentherapie und Onkologie.

[8]  Toshiaki Takahashi,et al.  Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study , 2016, Radiation Oncology.

[9]  A. Chaudhuri,et al.  Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. , 2016, International journal of radiation oncology, biology, physics.

[10]  Corinne Faivre-Finn,et al.  High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. , 2014, The Lancet. Oncology.

[11]  Max Dahele,et al.  High-dose, conventionally fractionated thoracic reirradiation for lung tumors. , 2014, Lung cancer.

[12]  J. Lovato,et al.  Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M. Mehta,et al.  Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Small Cell and Non–Small Cell Lung Carcinoma , 2014, American journal of clinical oncology.

[14]  H. Honda,et al.  Definitive fractionated re-irradiation for local recurrence following stereotactic body radiotherapy for primary lung cancer. , 2013, Anticancer research.

[15]  Steven F Petit,et al.  Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  E. Yorke,et al.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) , 2013, Radiation oncology.

[17]  F. Sedlmayer,et al.  DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume , 2013, Radiation oncology.

[18]  M. Martel,et al.  Aortic dose constraints when reirradiating thoracic tumors. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Joe Y. Chang,et al.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[20]  F. Tanaka,et al.  Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients. , 2012, Lung cancer.

[21]  K. Rosenzweig,et al.  Toxicity and Outcomes of Thoracic Re-irradiation Using Stereotactic Body Radiation Therapy: Improved Local Control with BED ≥ 100 Gy , 2011 .

[22]  B. Jeremic,et al.  Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. , 2011, International journal of radiation oncology, biology, physics.

[23]  P. Storchi,et al.  Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. , 2010, International journal of radiation oncology, biology, physics.

[25]  Dwight E Heron,et al.  Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. , 2008, Clinical lung cancer.

[26]  T. Tada,et al.  Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy , 2005, International Journal of Clinical Oncology.

[27]  John D Fenwick,et al.  A challenge to traditional radiation oncology. , 2004, International journal of radiation oncology, biology, physics.

[28]  G. Jiang,et al.  Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. , 2003, International journal of radiation oncology, biology, physics.

[29]  T. Nakajima,et al.  Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[30]  A. Manatunga,et al.  The Reirradiation of Recurrent Bronchogenic Carcinoma with External Beam Irradiation , 1993, American journal of clinical oncology.

[31]  R. Yaes.  Tumor heterogeneity, tumor size, and radioresistance. , 1989, International journal of radiation oncology, biology, physics.

[32]  R. Melbye,et al.  Lung cancer: Retreatment of local recurrence after definitive irradiation , 1982, Cancer.

[33]  Vitali Moiseenko,et al.  Radiation dose-volume effects in the heart. , 2010, International journal of radiation oncology, biology, physics.

[34]  M. Kinay,et al.  Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. , 2009, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.